$ETNB
89bio, Inc.

2022 Q3 Form 10-Q Financial Statement

#000156459022029093 Filed on August 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.844M $5.052M $5.259M
YoY Change 4.8% 2.66% 14.08%
% of Gross Profit
Research & Development $22.20M $19.69M $19.85M
YoY Change -5.91% 25.95% 95.92%
% of Gross Profit
Depreciation & Amortization $16.00K $16.00K $18.00K
YoY Change -30.43% 6.67% 20.0%
% of Gross Profit
Operating Expenses $27.04M $24.74M $19.85M
YoY Change -4.15% 20.37% 34.67%
Operating Profit -$27.04M -$24.74M -$25.11M
YoY Change -4.15% 20.37% 70.35%
Interest Expense $535.0K $434.0K $408.0K
YoY Change -208.5%
% of Operating Profit
Other Income/Expense, Net $238.0K -$316.0K -$456.0K
YoY Change -303.42% 83.72% 960.47%
Pretax Income -$26.80M -$25.05M -$25.56M
YoY Change -5.39% 20.9% 72.94%
Income Tax $2.000K $0.00 $1.000K
% Of Pretax Income
Net Earnings -$26.81M -$25.05M -$25.57M
YoY Change -5.38% 20.9% 72.95%
Net Earnings / Revenue
Basic Earnings Per Share -$0.57 -$1.23 -$1.26
Diluted Earnings Per Share -$0.57 -$1.23 -$1.257M
COMMON SHARES
Basic Shares Outstanding 39.07M 20.35M 20.34M
Diluted Shares Outstanding 47.25M 20.35M 20.34M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $193.3M $139.3M $126.1M
YoY Change 22.89% -18.51% -33.5%
Cash & Equivalents $72.40M $60.62M $54.89M
Short-Term Investments $120.9M $78.71M $71.20M
Other Short-Term Assets $6.513M $7.243M $9.323M
YoY Change -32.88% -24.63% 12.33%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $199.9M $146.6M $135.4M
YoY Change 19.65% -18.83% -31.58%
LONG-TERM ASSETS
Property, Plant & Equipment $105.0K $121.0K $138.0K
YoY Change -28.08% -21.43% -31.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $218.0K $797.0K $218.0K
YoY Change -75.06% -19.0% -63.67%
Total Long-Term Assets $726.0K $1.027M $356.0K
YoY Change -28.82% -9.75% -55.5%
TOTAL ASSETS
Total Short-Term Assets $199.9M $146.6M $135.4M
Total Long-Term Assets $726.0K $1.027M $356.0K
Total Assets $200.6M $147.6M $135.8M
YoY Change 19.35% -18.77% -31.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.15M $4.907M $4.421M
YoY Change 12.97% 156.24% -1.76%
Accrued Expenses $13.44M $14.39M $8.979M
YoY Change 83.59% 153.98% 130.23%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $6.667M $7.500M $5.000M
YoY Change
Total Short-Term Liabilities $34.42M $26.90M $18.40M
YoY Change 73.46% 254.87% 116.47%
LONG-TERM LIABILITIES
Long-Term Debt $12.96M $12.05M $14.47M
YoY Change 799.24% 745.02%
Other Long-Term Liabilities $624.0K $28.46M $151.0K
YoY Change
Total Long-Term Liabilities $12.96M $12.05M $14.47M
YoY Change 799.24% 745.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $34.42M $26.90M $18.40M
Total Long-Term Liabilities $12.96M $12.05M $14.47M
Total Liabilities $48.01M $67.41M $33.02M
YoY Change 125.52% 648.5% 288.52%
SHAREHOLDERS EQUITY
Retained Earnings -$290.6M -$263.8M -$238.8M
YoY Change 55.48% 73.18%
Common Stock $443.7M $344.3M $341.8M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $152.6M $80.19M $102.7M
YoY Change
Total Liabilities & Shareholders Equity $200.6M $147.6M $135.8M
YoY Change 19.35% -18.77% -31.66%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$26.81M -$25.05M -$25.57M
YoY Change -5.38% 20.9% 72.95%
Depreciation, Depletion And Amortization $16.00K $16.00K $18.00K
YoY Change -30.43% 6.67% 20.0%
Cash From Operating Activities -$14.81M -$14.84M -$24.34M
YoY Change 10.15% -26.23% 62.49%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $1.000K $6.000K
YoY Change -100.0% -105.0% 50.0%
Acquisitions
YoY Change
Other Investing Activities -$42.06M -$7.597M $26.78M
YoY Change -342.06% -45.17% -273.77%
Cash From Investing Activities -$42.06M -$7.596M $26.77M
YoY Change -342.28% -45.26% -273.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 68.63M 28.16M 29.00K
YoY Change 95220.83% 1568.25% -86.57%
NET CHANGE
Cash From Operating Activities -14.81M -14.84M -24.34M
Cash From Investing Activities -42.06M -7.596M 26.77M
Cash From Financing Activities 68.63M 28.16M 29.00K
Net Change In Cash 11.76M 5.729M 2.457M
YoY Change 195.35% -117.74% -108.14%
FREE CASH FLOW
Cash From Operating Activities -$14.81M -$14.84M -$24.34M
Capital Expenditures $0.00 $1.000K $6.000K
Free Cash Flow -$14.81M -$14.84M -$24.35M
YoY Change 10.28% -26.16% 62.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-64000
CY2022Q2 etnb Liability Related To Public Offering
LiabilityRelatedToPublicOffering
28200000
CY2022Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
139300000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
212000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
7000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-215000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
219000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35505000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
202961000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
216000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1793000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-14782000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
190195000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
152000
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
83000
CY2021Q2 etnb Issuance Of Common Stock Warrant In Connection With Term Loan Facility
IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
574000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2417000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-20723000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
172705000
us-gaap Profit Loss
ProfitLoss
-50619000
us-gaap Profit Loss
ProfitLoss
-35505000
us-gaap Share Based Compensation
ShareBasedCompensation
5098000
us-gaap Share Based Compensation
ShareBasedCompensation
4210000
etnb Accretion Of Final Payment Fee
AccretionOfFinalPaymentFee
245000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
152000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
194000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-128000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-472000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
91000
us-gaap Depreciation
Depreciation
34000
us-gaap Depreciation
Depreciation
35000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4037000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4032000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
507000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-77000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1936000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-159000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4194000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-383000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-96000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39179000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35091000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
59912000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
63952000
etnb Payment For Purchase Of Available For Sale Securities
PaymentForPurchaseOfAvailableForSaleSecurities
40731000
etnb Payment For Purchase Of Available For Sale Securities
PaymentForPurchaseOfAvailableForSaleSecurities
93218000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19176000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29286000
etnb Proceeds From Public Offering Prior To Closing
ProceedsFromPublicOfferingPriorToClosing
28186000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
43000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
83000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
29000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
368000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
69000
us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
1457000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28189000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1908000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8186000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-62469000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52457000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98208000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60643000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35739000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60618000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35714000
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60643000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35739000
us-gaap Interest Paid Net
InterestPaidNet
404000
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
127000
etnb Offering Costs Included In Other Assets And Accrued Expenses
OfferingCostsIncludedInOtherAssetsAndAccruedExpenses
580000
etnb Purchases Of Property And Equipment Included In Accounts Payable And Accrued Expenses
PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
3000
etnb Issuance Of Common Stock Warrant In Connection With Term Loan Facility
IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
574000
etnb Debt Issuance Costs Included In Accounts Payable
DebtIssuanceCostsIncludedInAccountsPayable
6000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-213217000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
125957000
CY2021Q4 us-gaap Liabilities
Liabilities
36465000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
20000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
162422000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
339218000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25761000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9529000
us-gaap Operating Expenses
OperatingExpenses
35290000
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2019-06-30
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.899
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.940
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.016
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.007
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.910
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.976
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.028
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.010
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
109000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
150000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
104000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2500000
CY2022Q2 etnb Liability Related To Public Offering
LiabilityRelatedToPublicOffering
28186000
CY2021Q4 etnb Other Non Current Liability
OtherNonCurrentLiability
30000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include but are not limited to the fair value of stock options and certain accrued expenses. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates. </p>
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
98000
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
7000
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
105000
CY2022Q2 etnb Operating Lease Imputed Interest
OperatingLeaseImputedInterest
1000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
104000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
us-gaap Other Than Temporary Impairment Loss Debt Securities Portion Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings
0
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
120726000
CY2021Q4 etnb Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
5277000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
126003000
CY2022Q2 etnb Prepaid Research And Development Current
PrepaidResearchAndDevelopmentCurrent
5061000
CY2021Q4 etnb Prepaid Research And Development Current
PrepaidResearchAndDevelopmentCurrent
7895000
CY2022Q2 us-gaap Prepaid Taxes
PrepaidTaxes
832000
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
836000
CY2022Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1325000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2506000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7218000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11237000
CY2022Q2 etnb Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
10827000
CY2021Q4 etnb Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
6195000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2208000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3168000
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1178000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
495000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
175000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
336000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14388000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10194000
CY2022Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
47000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
100000
CY2022Q2 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P0Y6M
etnb Operating Lease Liability Percentage
OperatingLeaseLiabilityPercentage
0.0425
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2500000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
10000000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
7500000
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
20000000
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
450000
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
19550000
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
7500000
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
12050000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2586000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2417000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5098000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4210000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3811845
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2545455
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
290000
CY2021Q4 us-gaap Assets
Assets
162422000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6843000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10194000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19537000
CY2021Q4 etnb Short Term Available For Sale Securities Current
ShortTermAvailableForSaleSecuritiesCurrent
98288000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11237000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
161982000
us-gaap Operating Income Loss
OperatingIncomeLoss
-35290000
CY2021Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
72000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
100000
etnb Percentage Of Fee On Loan
PercentageOfFeeOnLoan
0.050

Files In Submission

Name View Source Status
0001564590-22-029093-index-headers.html Edgar Link pending
0001564590-22-029093-index.html Edgar Link pending
0001564590-22-029093.txt Edgar Link pending
0001564590-22-029093-xbrl.zip Edgar Link pending
etnb-10q_20220630.htm Edgar Link pending
etnb-20220630.xsd Edgar Link pending
etnb-ex311_7.htm Edgar Link pending
etnb-ex312_6.htm Edgar Link pending
etnb-ex32_8.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
etnb-20220630_lab.xml Edgar Link unprocessable
etnb-20220630_def.xml Edgar Link unprocessable
etnb-20220630_pre.xml Edgar Link unprocessable
etnb-20220630_cal.xml Edgar Link unprocessable
etnb-10q_20220630_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable